Search research articles
Contact Us
Filters
Showing results (381-390 of 443) with videos related to
Page
of 45
Sort By:
The Lancet. Oncology
|
December 17, 2021
Sotorasib for previously treated colorectal cancers with KRAS<sup>G12C</sup> mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
Ji Son, Heather Y Lin, Siqing Fu, et al.
JCI Insight
|
April 20, 2017
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients
Vivek Subbiah, Muhammad Rizwan Khawaja, David S Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
The Lancet. Oncology
|
February 13, 2019
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial
Johann S de Bono, Nicole Concin, David S Hong, et al.
JCO Precision Oncology
|
July 9, 2025
Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
JCO Precision Oncology
|
February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Page
of 45
Search research articles
Search
Showing results (381-390 of 443) with videos related to
Sort By:
Page
of 45
The Lancet. Oncology
|
December 17, 2021
Sotorasib for previously treated colorectal cancers with KRAS<sup>G12C</sup> mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial
Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, et al.
Journal of Immunotherapy and Precision Oncology
|
February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer
Ji Son, Heather Y Lin, Siqing Fu, et al.
JCI Insight
|
April 20, 2017
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients
Vivek Subbiah, Muhammad Rizwan Khawaja, David S Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2023
Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated <i>KRAS</i> G12C-Mutated Non-Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
Journal of Immunotherapy and Precision Oncology
|
February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Cancer Medicine
|
February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma
Omar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.
Future Oncology (London, England)
|
November 27, 2023
Long-term benefit of sotorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: plain language summary
Grace K Dy, Ramaswamy Govindan, Vamsidhar Velcheti, et al.
The Lancet. Oncology
|
February 13, 2019
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial
Johann S de Bono, Nicole Concin, David S Hong, et al.
JCO Precision Oncology
|
July 9, 2025
Erratum: NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
JCO Precision Oncology
|
February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Vicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Page
of 45